Pure Bioscience Inc (PURE) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
771 JAMACHA ROAD #512 EL CAJON, CA 92019 |
| State of Incorp. | DE |
| Fiscal Year End | July 31 |
| Industry (SIC) | 289 - Miscellaneous Chemical Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 1/31/2026 MRQ | 7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | 7/31/2021 | 7/31/2020 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 334 | 349 | 1,095 | 3,391 | 2,390 | 3,839 | |||
| Cash and cash equivalent | 334 | 349 | 1,095 | 3,391 | 2,390 | 3,839 | |||
| Restricted cash and investments | 75 | ||||||||
| Receivables | 474 | 298 | 285 | 201 | 368 | 1,089 | |||
| Inventory, net of allowances, customer advances and progress billings | 141 | 56 | 88 | 179 | 332 | 547 | |||
| Inventory | 141 | 56 | 88 | 179 | 332 | 547 | |||
| Prepaid expense | 23 | 27 | 61 | 18 | 32 | 16 | |||
| Other undisclosed current assets | 75 | 75 | 75 | 75 | 75 | ||||
| Total current assets: | 1,047 | 805 | 1,604 | 3,864 | 3,197 | 5,566 | |||
| Noncurrent Assets | |||||||||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 11 | 13 | 221 | 620 | 740 | 316 | |||
| Intangible asset, including goodwill, after accumulated amortization | 366 | 441 | |||||||
| Intangible asset, excluding goodwill, after accumulated amortization | 366 | 441 | |||||||
| Total noncurrent assets: | 11 | 13 | 221 | 620 | 1,106 | 757 | |||
| TOTAL ASSETS: | 1,058 | 818 | 1,825 | 4,484 | 4,303 | 6,323 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 938 | 733 | 532 | 575 | 731 | 1,512 | |||
| Accounts payable | 784 | 601 | 422 | 488 | 593 | 1,344 | |||
| Accrued liabilities | 154 | 132 | 110 | 87 | 138 | 168 | |||
| Debt | 239 | ||||||||
| Other undisclosed current liabilities | |||||||||
| Total current liabilities: | 938 | 733 | 532 | 575 | 970 | 1,512 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 1,021 | ||||||||
| Long-term debt, excluding current maturities | 1,021 | ||||||||
| Other undisclosed noncurrent liabilities | 5,236 | 2,949 | |||||||
| Total noncurrent liabilities: | 5,236 | 2,949 | 1,021 | ||||||
| Total liabilities: | 6,174 | 3,682 | 1,553 | 575 | 970 | 1,512 | |||
| Equity | |||||||||
| Equity, attributable to parent | (5,116) | (2,864) | 272 | 3,909 | 3,333 | 4,811 | |||
| Common stock | 1,119 | 1,119 | 1,119 | 1,114 | 873 | 871 | |||
| Additional paid in capital | 132,759 | 132,612 | 132,398 | 132,079 | 128,253 | 127,414 | |||
| Accumulated deficit | (138,994) | (136,595) | (133,245) | (129,284) | (125,793) | (123,474) | |||
| Total equity: | (5,116) | (2,864) | 272 | 3,909 | 3,333 | 4,811 | |||
| TOTAL LIABILITIES AND EQUITY: | 1,058 | 818 | 1,825 | 4,484 | 4,303 | 6,323 | |||
Income Statement (P&L) ($ in thousands)
| 1/31/2026 TTM | 7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | 7/31/2021 | 7/31/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 2,198 | 1,955 | 1,871 | 1,813 | 3,698 | 6,917 | ||
| Cost of revenue (Cost of Product and Service Sold) | (899) | (811) | (906) | (853) | (1,852) | (2,896) | ||
| Other undisclosed gross profit | 4 | 8 | 6 | 40 | 229 | |||
| Gross profit: | 1,303 | 1,152 | 971 | 1,000 | 2,075 | 4,021 | ||
| Operating expenses | (3,575) | (4,343) | (4,914) | (4,724) | (4,386) | (4,017) | ||
| Operating income (loss): | (2,272) | (3,191) | (3,943) | (3,724) | (2,311) | 4 | ||
| Nonoperating income (expense) | (127) | (159) | (18) | 233 | (8) | 5 | ||
| Other nonoperating income (expense) | 172 | (4) | (4) | (4) | 5 | |||
| Interest and debt expense | (299) | (155) | (14) | 239 | (4) | (5) | ||
| Income (loss) from continuing operations: | (2,698) | (3,505) | (3,975) | (3,252) | (2,323) | 4 | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (3,252) | (2,323) | 4 | |
| Net income (loss): | (2,698) | (3,505) | (3,975) | (3,252) | (2,323) | 4 | ||
| Other undisclosed net income (loss) attributable to parent | 299 | 155 | 14 | (239) | 4 | |||
| Net income (loss) available to common stockholders, diluted: | (2,399) | (3,350) | (3,961) | (3,491) | (2,319) | 4 | ||
Comprehensive Income ($ in thousands)
| 1/31/2026 TTM | 7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | 7/31/2021 | 7/31/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (2,698) | (3,505) | (3,975) | (3,252) | (2,323) | 4 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (2,698) | (3,505) | (3,975) | (3,252) | (2,323) | 4 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.